Alto Neuroscience, Inc. (ANRO)
NYSE·Healthcare·Biotechnology
$22.04
+2.85%
Mkt Cap $640.82M
Analyst Ratings
Buy
11
Hold
3
Sell
0
Price Target (6 analysts)
$29.00
Range $24.00 – $35.00
Implied Upside
+31.6%
Consensus $29.00 vs current $22.04
NYSE·Healthcare·Biotechnology
$22.04
+2.85%
Mkt Cap $640.82M
Buy
11
Hold
3
Sell
0
Price Target (6 analysts)
$29.00
Range $24.00 – $35.00
+31.6%
Consensus $29.00 vs current $22.04